AH
Therapeutic Areas
Kaer Biotherapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AeroPulsR / SUPRAER Platform | Acute & Chronic Respiratory Disorders (e.g., in ICU, COPD, Asthma) | Pre-clinical |
| Industrial Automation for Animal Health | Mass Vaccination in Livestock | Development |
Leadership Team at Kaer Biotherapeutics
DY
Donovan Yeates, PhD
CEO & Founder
WF
Walter Flicker, M.Bio, MedEng
Director
JP
Johnathan Phillips, PhD
Director